Navigation Links
Current Status of the Development Programs of New Indications and Formulations for Aricept(R) for Enhancing Patient Value
Date:7/2/2009

TOKYO and WOODCLIFF LAKE, N.J., July 2 /PRNewswire/ -- Eisai Co., Ltd. (Headquarters: Tokyo, President & CEO: Haruo Naito, "Eisai") and Eisai Corporation of North America (Headquarters: Woodcliff Lake, NJ, Chairman and CEO Hajime Shimizu) are currently focusing on three clinical development programs for the company's major product Aricept(R) (donepezil hydrochloride tablets) to further contribute to patients with Alzheimer's disease. As progress in those programs has been made, Eisai announces the status as follows:

1. Sustained Release Tablets

Eisai has completed a Phase III study of Aricept 23 mg sustained release (SR) in patients with moderate to severe Alzheimer's disease. Aricept 23 mg SR is being developed to increase clinical benefits while maintaining a favorable safety profile compared to currently marketed Aricept 10 mg immediate release.

Based on the preliminary review of the data from this Phase III study, Eisai plans to submit a New Drug Application (NDA) with the U.S. Food and Drug Administration (FDA) in August or September 2009.

2. Pediatric Use

Eisai filed a Proposed Pediatric Study Request (PPSR), an application that proposes a rationale and study design for pediatric studies, with the U.S. FDA in February 2009 to evaluate the clinical benefits of donepezil in children with attention impairment following cancer treatment. Eisai received a notice from the U.S. FDA that there were insufficient grounds to issue a Written Request to obtain pediatric exclusivity. Eisai plans to complete the ongoing studies to provide important information on this therapeutic approach for an underserved patient population currently with limited treatment options.

3. Transdermal Patch Formulation

Clinical trials of a once-a-week transdermal patch formulation of donepezil, which include a bioequivalence study compared to the currently markete
'/>"/>

SOURCE Eisai Co., Ltd.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. New Study: Antidepressants Commonly Prescribed with Tamoxifen Put Women at Much Higher Risk for Recurrent Breast Cancer
2. New Phase 3 Study of Tapentadol Immediate Release Tablets Published in Current Medical Research and Opinion Journal
3. Expert Insights in Acute Lymphoblastic Leukemia: Current Challenges and Future Directions
4. Walter Reed Army Medical Center offers HIFU for Qualifying Men with Locally Recurrent Prostate Cancer in a Phase III Clinical Trial
5. Angiomax Will Retain Decision Resources Proprietary Clinical Gold Standard Status Over Current and New Therapies, Including Recently-Approved Efient, for the Treatment of NSTEMI
6. More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies
7. NanoBio Demonstrates New Topical Approach to Treating Nail Fungus That Circumvents Problems with Current Therapy
8. Analysis of Earlier European Stroke Trial Supports Treatment Regimen for Viprinex(TM) in Current International Phase 3 Clinical Trials
9. High Intensity Focused Ultrasound for Locally Recurrent Prostate Cancer Following External Beam Radiation Therapy Investigated in Phase III Clinical Study
10. Prasugrel Significantly Reduced New or Recurrent Heart Attacks in Both Acute and Longer-Term Settings Following PCI, Compared with Clopidogrel
11. Head-to-Head Study Showed Prasugrel Statistically Superior to Clopidogrel in Reducing Recurrent Cardiovascular Events
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2015)... LOUIS, July 28, 2015  Express Scripts Holding Company ... income attributable to Express Scripts stockholders of $600.1 million, ... share, as detailed in Table 4, were $1.44 for ... is clear many companies across healthcare are validating the ... and Chief Executive Officer. "But, what matters most is ...
(Date:7/28/2015)... , July 28, 2015 /PRNewswire-USNewswire/ -- ... abuse and doctor shopping after a 2012 law required ... and addictive medications is yet more evidence that Californians ... Since Kentucky,s prescription ... "doctor shopping" declined by 52 percent; opioid prescriptions to ...
(Date:7/28/2015)... 2015 A German Diabetes Center clinical study ... probiotic enriches human gut microbiota and modifies gut ... study involved daily administration of Nutraceutix,s L. reuteri ... patented BIO- tract ® delivery technology that ... their way to the intestinal tract. The ...
Breaking Medicine Technology:Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 2Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 3Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 4Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 5Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 6Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 7Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 8Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 9Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 10Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 11Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 12Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 13Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 14Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 15Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 16Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 17Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 18Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 19Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 20Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 21Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 22Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 23Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 24Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 25Study Shows Requiring Prescription Drug Database Use Before Prescribing Powerful, Addictive Medications Critical In Ending Growing Epidemic, says Consumer Watchdog 2Nutraceutix's L. reuteri Probiotic Clinically Proven to Modulate Gut Insulin Metabolism 2
(Date:7/29/2015)... ... July 29, 2015 , ... It is unique for ... is a tremendous model of care. One that is very hands on and resident ... director of Monarch Landing. “She’s bringing great passion and energy, as well as a ...
(Date:7/29/2015)... Palatine, IL (PRWEB) , ... July 29, 2015 , ... ... the ever-expanding population of children with autism, Little City took a proactive stance and ... and occupied. The Coleman Foundation grant provides valuable support to building the third home. ...
(Date:7/29/2015)... ... July 29, 2015 , ... Zofran lawsuits around the nation ... Litigation (JPML), according to court documents.* Attorneys handling Zofran lawsuits provide ... Defects Lawsuit Center. , GlaxoSmithKline, the global pharmaceutical conglomerate and defendant in national ...
(Date:7/29/2015)... ... , ... " mybody ” was featured on NewsWatch as part of its ... an impact in their industry. Andrew Tropeano, the host of NewsWatch and business expert, ... are designed to strengthen the skin’s defense system from the inside out. , According ...
(Date:7/29/2015)... ... 29, 2015 , ... HealthPostures ( https://healthpostures.com ), a sit ... an ergonomics specialty firm. Purpose of the partnership is to help strengthen and ... improve worker mobility, functionality and fitness levels. , Executives at HealthPostures and ...
Breaking Medicine News(10 mins):Health News:New Medical Director Readies To Take Reins at Monarch Landing 2Health News:New Medical Director Readies To Take Reins at Monarch Landing 3Health News:Little City Receives $500,000 Matching Grant from The Coleman Foundation 2Health News:Little City Receives $500,000 Matching Grant from The Coleman Foundation 3Health News:Zofran Lawsuit News: Zofran Lawsuits Stayed, Awaiting MDL Decision 2Health News:Zofran Lawsuit News: Zofran Lawsuits Stayed, Awaiting MDL Decision 3Health News:Zofran Lawsuit News: Zofran Lawsuits Stayed, Awaiting MDL Decision 4Health News:Strengthen the Skin’s Defense System from the Inside Out with mybody 2Health News:HealthPostures and 247Ergo Partnership Strengthens America's Wellness 2Health News:HealthPostures and 247Ergo Partnership Strengthens America's Wellness 3
... ... Ovu-Trac®, an Ovulation Predictor Kit now available in the United States ... accuracy. This fertility predictor has been used successfully by tens of ... Administration requirements for legal sale in the United States. The kit allows ...
... Bariatric ... (7th) consecutive year and will be located in Booth #1011. , ... Irvine, CA (PRWEB) June 18, 2009 -- Bariatric ... seventh (7th) consecutive year and will be located in Booth #1011. "Bariatric Advantage is ...
... different approach to choosing the best treatment options for early ... experts in a report from the 11th St Gallen conference. ... Annals of Oncology [1] today (Thursday 18 June), ... emerged from the conference of more than 4,800 participants from ...
... to Mayo Clinic for patients from around the region, nation and ... are available on the Mayo Clinic News Blog: http://newsblog.mayoclinic.org/2009/06/16/mayo-clinic-gateway/ ... Mayo Clinic announced today that it has signed a letter of ... of Mall of America (R). Over the next 12 months, ...
... Doctors at Allure Medical Spa Are First in Michigan to Use ... --The rumor has been out for a while that the new ... ever competition in the fight against wrinkles. While the jury ... in Shelby Township, is the first medical office in Michigan to ...
... for delinquent kids showed surprise benefit , WEDNESDAY, June ... history of juvenile delinquency in specialized foster-care programs had ... researchers found. , Researchers directed 166 girls aged 13 ... receive treatment for criminal behavior to either specialized foster ...
Cached Medicine News:Health News:Ovu-Trac(R) Home Test Kit From OvumOptics Predicts Ovulation with 96.2% Accuracy 2Health News:Ovu-Trac(R) Home Test Kit From OvumOptics Predicts Ovulation with 96.2% Accuracy 3Health News:Ovu-Trac(R) Home Test Kit From OvumOptics Predicts Ovulation with 96.2% Accuracy 4Health News:Bariatric Advantage Will Be in Attendance at the 26th Annual American Society of Metabolic and Bariatric Surgery in Dallas, Texas 2Health News:St. Gallen consensus 2009: A radically different approach to treating early breast cancer 2Health News:St. Gallen consensus 2009: A radically different approach to treating early breast cancer 3Health News:Mayo Clinic Plans Facility at Mall of America 2Health News:Mayo Clinic Plans Facility at Mall of America 3Health News:Does Botox(R) Finally Have Competition? 2Health News:Close Monitoring May Help Troubled Teen Girls Avoid Pregnancy 2
Anterior Chamber Needle, 23 g. Angled. 7 mm angled tip. Overall length 23 mm. 5/box....
Hydrodissection / Aspiration Cannula, 25 g. Angled with right hook. 10 mm angled shaft with 2.5 mm right hook tip. Overall length 20 mm. 5/box....
Silicone Capsule Polisher, 27 g. Silicon tip to provide squeegee effect. Overall length 22 mm. 5/box....
Cystotome Curved, Twisted Tip, 27 g. Twisted tip places cutting edge in line with cannula shaft for vertical cuts during capsulotomies. Overall length 14 mm. 5/box....
Medicine Products: